Patent Prosecution

For 45 years, Sterne Kessler has protected innovation, providing strategic counsel from idea conception and product development to commercialization, launch, and beyond.

Leadership

Carla Ji-Eun Kim Director

Related News & Insights

In the News

January 3, 2024

Teva Defeats Infringement Claims on Endocrine Drug

New Jersey Law Journal

Firm Announcements

January 3, 2024

Federal Circuit Affirms Sweet Win for SweeGen in Patent Invalidity Battle

Sterne, Kessler, Goldstein & Fox

Firm Announcements

January 3, 2024

Sterne Kessler Secures Non-Infringement Win for Teva Pharmaceuticals

Sterne, Kessler, Goldstein & Fox